About PPD Pharmaceutical Development India Private Limited
Data last updated:
PPD Pharmaceutical Development India Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ppd Uk Holdings Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 February 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2004PTC144454. Its GSTIN is 27AADCP2043E1ZT (Maharashtra). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹3.15 Cr and a paid-up capital of ₹3.56 Lakh. It is led by directors Rashmi Raja Chitgupi and Hemant Shah.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wing Fulcrum Hiranandani Business Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹457.7 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹42.97 Cr (net margin 9.4%) and EBITDA of ₹78.14 Cr (EBITDA margin 17.1%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 21% over five years.
The company has about 1,674 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: PPD. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹73.6 Cr; the latest was in January 2019. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Jubilant Biosys Limited with revenue of ₹562.86 Cr. The company has 11 MSME Form 1 returns on record between 2020 and 2024, listing 97 overdue payments to 12 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ppd.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address102 A – Wing Fulcrum Hiranandani Business Park, Sahar Road Andheri(East), Mumbai, Maharashtra, India – 400099
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of PPD Pharmaceutical Development India Private Limited
The main business activity of PPD Pharmaceutical Development India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of PPD Pharmaceutical Development India Private Limited FY 2025 filings available
PPD Pharmaceutical Development India Private Limited reported revenue of ₹457.7 Cr (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of PPD Pharmaceutical Development India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 19% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of PPD Pharmaceutical Development India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹78.14 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹42.97 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of PPD Pharmaceutical Development India Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 9.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of PPD Pharmaceutical Development India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India has 2 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rashmi Raja Chitgupi | Director | 16 Oct 2020 | 6 Years 0 Months | Current |
| Hemant Shah | Director | 18 Aug 2020 | 6 Years 2 Months | Current |
Peer Comparison of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jubilant Biosys Limited | ₹562.86 Cr (FY 2023) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
| Graviti Pharmaceuticals Private Limited | ₹543.75 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Hyderabad, Telangana, India |
| Hyclone Life Sciences Solutions India Private Limited | ₹539.19 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Bangalore, Karnataka, India |
| Fortrea Development India Private Limited | ₹535.42 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
| TCG Lifesciences Private Limited | ₹482.95 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Kolkata, West Bengal, India |
| PPD Pharmaceutical Development India Private Limited this company | ₹457.7 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Biophore India Pharmaceuticals Private Limited | ₹457 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Hyderabad, Telangana, India |
| Axis Clinicals Limited | ₹386.63 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Syngene Scientific Solutions Limited | ₹334.5 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Bangalore, Karnataka, India |
| Curia India Private Limited | ₹282.6 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
| Adgyl Lifesciences Private Limited | ₹272.09 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below PPD Pharmaceutical Development India by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited is audited by Price Waterhouse & Co Chartered Accountants LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Price Waterhouse & Co Chartered Accountants LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of PPD Pharmaceutical Development India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹73.6 Cr; the latest was in January 2019.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2019 | Funding round | ₹70.46 Cr | Investors: PPD UK Holdings Limited |
| Jul 2010 | Funding round | ₹3.14 Cr | Investors: PPD UK Holdings Limited, PPD Global Limited |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited has 2 court cases on record: 2 filed against it. All cases are pending. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
| District courts | 1 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed against the company by an individual | Pending |
| District court, BENGALURU, Karnataka | Court case (ID) | Filed against the company by an individual | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited has 11 MSME Form 1 returns on record between 2020 and 2024, listing 97 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Superior Document | •••• | •••• | •••• |
| 3S Security Systems | •••• | •••• | •••• |
| Amps Facilities Management Services Private Limited | •••• | •••• | •••• |
| Rentokil Initial Hygiene India Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited has a workforce of 1,674 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India Private Limited has 15 board changes on record since 2006: 2 appointments and 13 cessations. The latest: Hemant Shah ceased to be Additional Director on 30 Nov 2020.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for PPD Pharmaceutical Development India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of PPD Pharmaceutical Development India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCP2043E1ZT | Maharashtra | Active | 01 Jul 2017 |
| 27AADCP2043E2ZS | Maharashtra | Active | 01 Mar 2025 |
| 06AADCP2043E1ZX | Haryana | Active | 01 Jul 2017 |
| 29AADCP2043E1ZP | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of PPD Pharmaceutical Development India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about PPD Pharmaceutical Development India Private Limited
Frequently Asked Questions about PPD Pharmaceutical Development India Private Limited
PPD Pharmaceutical Development India is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 February 2004 (22+ years old) and is registered under CIN U73100MH2004PTC144454.
PPD Pharmaceutical Development India reported revenue of ₹457.7 Cr for FY 2025 (up 19% YoY).
PPD Pharmaceutical Development India has 2 current directors:
- Rashmi Raja Chitgupi - Director
- Hemant Shah - Director
PPD Pharmaceutical Development India reported a net profit of ₹42.97 Cr (net margin 9.4%) and EBITDA of ₹78.14 Cr (EBITDA margin 17.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of PPD Pharmaceutical Development India is 12% over three years and 21% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of PPD Pharmaceutical Development India is 27AADCP2043E1ZT, registered in Maharashtra. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 27AADCP2043E2ZS (Maharashtra), 06AADCP2043E1ZX (Haryana), 29AADCP2043E1ZP (Karnataka).
The CIN (Corporate Identification Number) of PPD Pharmaceutical Development India is U73100MH2004PTC144454. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
PPD Pharmaceutical Development India has 2 court cases on record: 2 filed against it. 2 are pending. Most are in the high courts.
PPD Pharmaceutical Development India was incorporated on 10 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
PPD Pharmaceutical Development India has 2 deals on record (2 funding rounds), with disclosed funding of ₹73.6 Cr; the latest was in January 2019.
The peers of PPD Pharmaceutical Development India by revenue are Jubilant Biosys Limited, Graviti Pharmaceuticals Private Limited, Hyclone Life Sciences Solutions India Private Limited, Fortrea Development India Private Limited, TCG Lifesciences Private Limited and 5 more, all in the Pharma industry (Contract Research).
Hemant Shah ceased to be Additional Director on 30 Nov 2020. Rashmi Raja Chitgupi ceased to be Additional Director on 30 Nov 2020. Rashmi Raja Chitgupi was appointed as Director on 16 Oct 2020. PPD Pharmaceutical Development India has 15 board changes on record in total.